Blog

Elizabeth Gargill

Recent Posts

BBK Worldwide Recognized Among World's Most Disruptive Pharma Services Innovators

Posted by Elizabeth Gargill on Tue, Feb 16, 2021

 

 

BBK Worldwide Featured in Newly-Published Innovations in Pharmaceutical Development

 

Guide Provides In-Depth Profiles of World’s Most Disruptive Pharma Services Innovators

BBK Worldwide has been recognized as a top innovator in Innovations in Pharmaceutical Development™. This newly-published guide highlights the companies and thought leaders at the forefront of innovation in the pharmaceutical development space. 

Read More

Topics: TrialCentralNet, Patient Experience, Clinical Trial Innovations, Innovations in Pharmaceutical Development

2021: A Look Inside Our Crystal Ball (part two)

Posted by Elizabeth Gargill on Tue, Dec 22, 2020

 

For part two of our Crystal Ball series, we asked a few more of our industry experts to comment on the clinical research landscape and to share their predictions for 2021.

Rob Laurens, Principal, RSG Services

 

Do you think a lot of the travel services rapidly deployed in response to COVID-19 will remain in effect? Will they become part of the standard offering?

Undoubtedly, many of the extraordinary support services deployed as a means to directly respond to the impact of the COVID-19 pandemic on clinical trial participant travel not only will remain available after the distribution and anticipated positive impact of vaccines, but also will be enhanced to serve the needs of a redefined approach and capabilities for clinical trial conduct by sponsors and CROs. 

Read More

Topics: BBK Worldwide, Patient Engagement, Patient Travel, Patient Experience, Patient Enrollment, Rob Laurens, Aaron Fleishman, Clinical Trial Patient Travel, Decentralized Trials, Virtual, Hybrid Trials, 2021 Predictions, 2021

2021: A Look Inside Our Crystal Ball (part one)

Posted by Elizabeth Gargill on Mon, Dec 21, 2020

 

As part of our Crystal Ball series, we asked BBK Worldwide President Matt Kibby to share his predictions for 2021, which include engaging  underrepresented populations in clinical research.

Matt Kibby, Principal, President

Is there a particular trend that you expect to have a significant impact on the industry in the coming year?

 

With COVID-19 dominating the headlines for much of 2020, one might expect that a key development for clinical R&D in 2021 will be the continued integration and expansion of services that support the hybridization / decentralization of clinical trials. Keeping trial participants – who tend to be older and at greater risk for complications from COVID-19 – away from clinical trial sites not only reduces the risk of SARS-COV-2 infection, but also offers the possibility of enrichment of the clinical trial experience; reduces the overall visit and expense burden for patients; and, moreover, reduces the trial burden on clinical trial site healthcare professionals.

Read More

Topics: BBK Worldwide, Patient Engagement, Patient Travel, Patient Experience, Patient Enrollment, Matt Kibby, Clinical Trial Patient Travel, 2021 Predictions, 2021, Underserved Populations

Survey Reveals Site Perspectives on Clinical Trial Services

Posted by Elizabeth Gargill on Tue, Dec 1, 2020

What do doctors and nurses think about solutions designed to make clinical trials easier to conduct? Are they helpful? Do they alleviate burdens? And which ones do they prefer?

In this special Pharma15 Live! segment, BBK Worldwide industry experts Matt Kibby and Aaron Fleishman discuss recent Study Voices survey results that shed light on this topic. They examine doctor and nurse perspectives on services designed to provide support in conducting clinical trials — including services for virtual, hybrid, and decentralized clinical trials.

“We were looking at whether or not doctors and nurses at sites that were conducting clinical trials would appreciate different types of services that assist with their ability to conduct them."

-Matt Kibby, Principal, President, BBK Worldwide

Read More

Topics: Clinical Trials, Pharma15 Live!, Study Voices, COVID-19, Matt Kibby, Aaron Fleishman, Decentralized Trials, Virtual, Study Voices 2020, Surveys, Site Voice, Hybrid Trials

Clinical Trial Innovation: More Important Now Than Ever

Posted by Elizabeth Gargill on Thu, Nov 19, 2020

 

Clinical Trial Innovation: More Important Now Than Ever

A new survey gives voice to the healthcare consumer in the wake of COVID-19 and highlights the importance of innovation in clinical trial patient enrollment and engagement.

DOWNLOAD NOW

New data provides clinical trial sponsors with the information they need to confidently embrace innovative solutions in response to COVID-19. The Study Voices 2020* survey reflects perspectives from patients, medical professionals, and members of the pharmaceutical industry. The findings reveal shifts in attitudes and behaviors since the onset of COVID-19 – insight that clinical trial sponsors can leverage for enrollment and engagement efforts, including for hybrid and virtual study models.

Read More

Topics: Patient Engagement, Patient Experience, Healthcare Consumer, COVID-19, International Clinical Trials, Patient Voice, Telehealth, Elizabeth Gargill, Study Voices 2020, Surveys, Site Voice, Publications

Why It’s Now Easier than Ever to Engage with Patients Wherever They Are

Posted by Elizabeth Gargill on Thu, Oct 15, 2020

 

Clinical trial sponsors now have access to several new solutions that make it possible to engage with patients wherever they are now more important than ever before as trials shift to hybrid and decentralized models.

Sponsors can transform their clinical trials with engagement solutions that prioritize patient care and convenience, helping maintain study momentum during COVID-19 and beyond.

Read More

Topics: Apps, Patient Experience, Study Voices, Patient Reimbursement, Patient Portals, Clinical Trial Innovations, COVID-19, Medication Delivery, In-home Nurse Visits

Ready, Set, Go Virtual!

Posted by Elizabeth Gargill on Tue, Oct 6, 2020

 

Ready, Set, Go Virtual!

New virtual engagement solutions are delivering patients the convenience and immediacy they want in their healthcare experience. Solutions that support decentralized or hybrid trials, like BBK’s virtual RSG® Card, are helping to remove some of the barriers to clinical trial participation that patients cite as the most challenging.

As a matter of fact, in BBK's recent Study Voices 2020 survey, patients selected "immediate reimbursement for study-related expenses" as the most important solution influencing their decision to participate in a clinical trial.

Read More

Topics: Patient Engagement, Patient Experience, Study Voices, Patient Reimbursement, RSG Card, Clinical Trial Innovations, Decentralized Trials, Virtual, Stipends

Study Voices 2020: Survey Findings Vol. 1

Posted by Elizabeth Gargill on Tue, Sep 29, 2020

 

During the last two weeks of August we surveyed more than 1,200 healthcare consumers, medical professionals, and members of the pharmaceutical industry for their perspectives on topics impacting today's healthcare consumer.

The findings provide a unique look at current attitudes and behaviors that inform the patient experience. They provide clinical trial sponsors with a snapshot of a critical moment in time when we're seeing the rise of telehealth, the adoption of decentralized and hybrid trials, and heightened awareness of clinical research. They also reveal new opportunities and challenges ahead for clinical trial enrollment and engagement.

Download Now

Read More

Topics: Patient Experience, Study Voices, Healthcare Consumer, Survey, Clinical Trial Innovations, COVID-19, Telehealth

Jessica Kim Named to PharmaVOICE 100 for Her Leadership and Expertise

Posted by Elizabeth Gargill on Tue, Sep 1, 2020

 

BBK Worldwide is honored to announce that our Creative Director for Patient Experience and Engagement, Jessica Kim, has been named to the 2020 PharmaVOICE 100 list of the most inspiring people in the life sciences industry as a patient champion. The award recognizes Ms. Kim for how she inspires and motivates those around her, her influence as a corporate leader, and her positive impact on the industry through her actions.

Read More

Topics: Patient Engagement, Patient Enrollment, Study-life Balance, PharmaVOICE, Jessica Kim, PharmaVOICE 100

Rob Laurens Discusses Navigating Patient Travel During COVID-19 with Outsourcing-Pharma

Posted by Elizabeth Gargill on Wed, Aug 19, 2020

 

Earlier this week, Principal of RSG Services Rob Laurens went one-on-one with Outsourcing-Pharma to discuss challenges associated with patient travel as COVID-19 restrictions ease.

In this in-depth interview, Rob addresses the importance of contingency planning, lessons learned, and the long-term impact of COVID-19 on patient travel. He also provides insight into services and resources that clinical trial sponsors can leverage to maximize patient safety and engagement during COVID-19 and beyond. Click here to read the full article.

Read More

Topics: Patient Travel, Patient Travel Programs, RSG Arrive, COVID-19, Rob Laurens, RSG Services, Outsourcing-Pharma